FENNEC PHARMACEUTICALS INC.

FENCReported to SECin USCIK 0001211583Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 35. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 35
Form 4 lines at FENNEC PHARMACEUTICALS INC., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Cioffi Christiana MarieChief Strategy OfficerAwardnothing paid156 sharesOct 1, 2026Cioffi Christiana MarieChief Strategy Officernothing paidAward · Oct 1Award156Oct 1, 2026
Sayad Pierre SargisChief Medical OfficerAwardnothing paid168 sharesOct 1, 2026Sayad Pierre SargisChief Medical Officernothing paidAward · Oct 1Award168Oct 1, 2026
Evans Terry LChief Commercial OfficerAwardnothing paid168 sharesOct 1, 2026Evans Terry LChief Commercial Officernothing paidAward · Oct 1Award168Oct 1, 2026
Hackman Jeffrey S.Chief Executive OfficerAwardnothing paid1,159 sharesOct 1, 2026Hackman Jeffrey S.Chief Executive Officernothing paidAward · Oct 1Award1,159Oct 1, 2026
Andrade RobertCHIEF FINANCIAL OFFICERAwardnothing paid1,703 sharesOct 1, 2026Andrade RobertCHIEF FINANCIAL OFFICERnothing paidAward · Oct 1Award1,703Oct 1, 2026